Bosh sahifaSOBI • STO
add
Swedish Orphan Biovitrum AB (publ)
Yopilish kursi
293,00 kr
Kunlik diapazon
296,60 kr - 305,40 kr
Yillik diapazon
241,80 kr - 354,40 kr
Bozor kapitalizatsiyasi
106,73 mlrd SEK
Oʻrtacha hajm
346,51 ming
Narx/foyda
26,26
Dividend daromadliligi
-
Asosiy maydon
STO
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (SEK) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 6,46 mlrd | 3,34% |
Joriy xarajat | 3,52 mlrd | 7,71% |
Sof foyda | 875,00 mln | 9,38% |
Sof foyda marjasi | 13,53 | 5,79% |
Har bir ulushga tushum | 2,72 | 1,87% |
EBITDA | 2,39 mlrd | 0,42% |
Amaldagi soliq stavkasi | 20,16% | — |
Balans
Jami aktivlari
Jami passivlari
| (SEK) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 997,00 mln | 89,18% |
Jami aktivlari | 70,12 mlrd | -5,90% |
Jami passivlari | 31,08 mlrd | -19,51% |
Umumiy kapital | 39,04 mlrd | — |
Tarqatilgan aksiyalar | 343,46 mln | — |
Narxi/balansdagi bahosi | 2,58 | — |
Aktivlardan daromad | 4,98% | — |
Kapitaldan daromad | 6,58% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (SEK) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 875,00 mln | 9,38% |
Operatsiyalardan naqd pul | 2,30 mlrd | 1,73% |
Sarmoyadan naqd pul | -94,00 mln | 87,38% |
Moliyadan naqd pul | -2,29 mlrd | -22,95% |
Naqd pulning sof oʻzgarishi | -143,00 mln | 62,07% |
Boʻsh pul | 2,38 mlrd | 2 297,81% |
Haqida
Swedish Orphan Biovitrum AB is an international biopharmaceutical company dedicated to treatments in the areas of haematology, immunology and specialty care, based in Stockholm, Sweden.
In 2020 it had a revenue of SEK 15.261 billion and 1,509 employees. Wikipedia
Tashkil etilgan
1939
Sayt
Xodimlar soni
1 895
